chart and comments, page-7

Sorry, I should have been more explicit. Within the infrastructure I was referring to the process and logistics. A lot of work has been done in this area and would provide the platform for a valuable service. Dendritic cell immunotherapy is the science du jour, with a number of companies developing various angles within this field. Prima is has the largest and widest ranging production and manufacturing process set up for this technology.

But yes, if CVac failed to demonstrate efficacy, I would expect to see us in the 3's or lower. But the first clue of whether that will happen or not is end of this year. The channel would have dropped through 4c by then at its current rate of decent, correct?
So we would have to expect a massive drop of about 50-60% based on the news of Dr Frazer leaving? or some other non-CVac news between now and the few months it takes for the channel to force us to 4?